Mast cell stabilizing properties of antihistamines

Francesca Levi-Schaffer; Ron Eliashar

doi:10.1038/jid.2009.256

Mast cell stabilizing properties of antihistamines

Francesca Levi-Schaffer^*, Ron Eliashar

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

27 Scopus citations

Abstract

Histamine is a key mediator of allergic inflammation, primarily through competitive antagonism of binding to H1 receptors. In this issue, Weller and Maurer report that the H1 antagonist desloratadine possesses mast cell-stabilizing properties when challenged in an IgE-dependent or-independent fashion. Thus, desloratadine provides benefits that are independent of H1 receptor binding and based on mast cell stabilization.

Original language	English
Pages (from-to)	2549-2551
Number of pages	3
Journal	Journal of Investigative Dermatology
Volume	129
Issue number	11
DOIs	https://doi.org/10.1038/jid.2009.256
State	Published - Nov 2009

Bibliographical note

Funding Information:
F. Levi-Schaffer is the recipient of grant funds from the Aimwell Charitable Trust (UK), the Israel Science Foundation, and the Israel Ministry of Health. Dr Levi-Schaffer is a member of the David R Bloom Center for Pharmacy and the Dr Adolph and Klara Brettler Center for Research in Molecular Pharmacology and Therapeutics in the School of Pharmacy, the Hebrew University of Jerusalem.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/jid.2009.256

Cite this

@article{17b92f862e484eb086f374e955c0f68d,

title = "Mast cell stabilizing properties of antihistamines",

abstract = "Histamine is a key mediator of allergic inflammation, primarily through competitive antagonism of binding to H1 receptors. In this issue, Weller and Maurer report that the H1 antagonist desloratadine possesses mast cell-stabilizing properties when challenged in an IgE-dependent or-independent fashion. Thus, desloratadine provides benefits that are independent of H1 receptor binding and based on mast cell stabilization.",

author = "Francesca Levi-Schaffer and Ron Eliashar",

note = "Funding Information: F. Levi-Schaffer is the recipient of grant funds from the Aimwell Charitable Trust (UK), the Israel Science Foundation, and the Israel Ministry of Health. Dr Levi-Schaffer is a member of the David R Bloom Center for Pharmacy and the Dr Adolph and Klara Brettler Center for Research in Molecular Pharmacology and Therapeutics in the School of Pharmacy, the Hebrew University of Jerusalem.",

year = "2009",

month = nov,

doi = "10.1038/jid.2009.256",

language = "אנגלית",

volume = "129",

pages = "2549--2551",

journal = "Journal of Investigative Dermatology",

issn = "0022-202X",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - Mast cell stabilizing properties of antihistamines

AU - Levi-Schaffer, Francesca

AU - Eliashar, Ron

N1 - Funding Information: F. Levi-Schaffer is the recipient of grant funds from the Aimwell Charitable Trust (UK), the Israel Science Foundation, and the Israel Ministry of Health. Dr Levi-Schaffer is a member of the David R Bloom Center for Pharmacy and the Dr Adolph and Klara Brettler Center for Research in Molecular Pharmacology and Therapeutics in the School of Pharmacy, the Hebrew University of Jerusalem.

PY - 2009/11

Y1 - 2009/11

N2 - Histamine is a key mediator of allergic inflammation, primarily through competitive antagonism of binding to H1 receptors. In this issue, Weller and Maurer report that the H1 antagonist desloratadine possesses mast cell-stabilizing properties when challenged in an IgE-dependent or-independent fashion. Thus, desloratadine provides benefits that are independent of H1 receptor binding and based on mast cell stabilization.

AB - Histamine is a key mediator of allergic inflammation, primarily through competitive antagonism of binding to H1 receptors. In this issue, Weller and Maurer report that the H1 antagonist desloratadine possesses mast cell-stabilizing properties when challenged in an IgE-dependent or-independent fashion. Thus, desloratadine provides benefits that are independent of H1 receptor binding and based on mast cell stabilization.

UR - http://www.scopus.com/inward/record.url?scp=70350046945&partnerID=8YFLogxK

U2 - 10.1038/jid.2009.256

DO - 10.1038/jid.2009.256

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 19826448

AN - SCOPUS:70350046945

SN - 0022-202X

VL - 129

SP - 2549

EP - 2551

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

IS - 11

ER -

Mast cell stabilizing properties of antihistamines

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this